{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/crohns-disease/management/confirmed-crohns-disease/","result":{"pageContext":{"chapter":{"id":"b3e71531-764c-58b2-aa02-ece1993fb53f","slug":"confirmed-crohns-disease","fullItemName":"Scenario: Confirmed Crohn's disease","depth":2,"htmlHeader":"<!-- begin field 874fe9e3-6c70-41ac-9f2c-7efb6df8d5f9 --><h2>Scenario: Confirmed Crohn's disease</h2><!-- end field 874fe9e3-6c70-41ac-9f2c-7efb6df8d5f9 -->","summary":"Covers the management of confirmed Crohn's disease in primary care.","htmlStringContent":"<!-- begin item bdb8b616-c705-4a5b-a2bc-f6b5556268d0 --><!-- begin field 9c7f98fb-a9a0-4d4b-aae9-acbd00876d17 --><p>From age 6 months onwards.</p><!-- end field 9c7f98fb-a9a0-4d4b-aae9-acbd00876d17 --><!-- end item bdb8b616-c705-4a5b-a2bc-f6b5556268d0 -->","topic":{"id":"a55bf0e9-c7ea-505e-b7ff-5093105336e5","topicId":"7057d96d-a527-4391-84a1-c39953de3eae","topicName":"Crohn's disease","slug":"crohns-disease","lastRevised":"Last revised in August 2020","chapters":[{"id":"9c1b7d20-f572-5a3c-845f-3f4b65f646e1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6b9f2bb0-4b7b-5373-ace6-15e38cc8904f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2a50fc53-dced-5bb1-83cf-20d5ce4f9e8e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"a5629107-6649-5a0c-a706-90ad8bf14aa7","slug":"changes","fullItemName":"Changes"},{"id":"1a920dcd-3a15-527f-9fc2-97be951c56cc","slug":"update","fullItemName":"Update"}]},{"id":"79cdca68-ce3a-5435-bca1-8393c4d809a6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"123f065a-c1e6-59ef-a0f6-fa3212214c90","slug":"goals","fullItemName":"Goals"},{"id":"d3e5c61e-a5b9-586a-8698-69a0c0f79a5f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b41011e0-33e6-52d3-9434-5f29d0baeeb8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f3bcc082-58a6-51db-a805-173080268884","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a5948dc8-4eac-58f3-8d64-68a80aeb4059","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7082be71-4889-5e95-bd5f-27917f361203","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"65c06b36-b686-57f1-be7f-6fae62c4deb0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3fa00303-9d62-51cf-819b-dbad0041831e","slug":"definition","fullItemName":"Definition"},{"id":"6890604a-a1f2-5be2-94b0-d2471c85fdbc","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"0d0050de-d075-540a-9c7c-ed50c6ed1243","slug":"prevalence","fullItemName":"Prevalence"},{"id":"05aa7fe4-c9b9-51f0-bf41-2369861eba6c","slug":"complications","fullItemName":"Complications"},{"id":"67cb018a-e79e-5636-bd84-67fe57bf28c2","slug":"extra-intestinal-manifestations","fullItemName":"Extra-intestinal manifestations"},{"id":"d2c1974d-3136-58a1-b5ba-55826ab8a286","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"14a7e92b-d43e-5b64-b357-c1a4d063afb3","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"32cf487b-92a9-5d33-949e-023023aede46","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"5440444f-1635-5240-bea3-54d84e6067f5","slug":"investigations","fullItemName":"Investigations"},{"id":"f7a2e718-21ad-5956-a862-8f8406ca2f8b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"a49169c9-856e-51c3-94cc-76e3f02f6073","fullItemName":"Management","slug":"management","subChapters":[{"id":"c4ee1de2-52a2-5289-82bd-c3377ae84b6c","slug":"suspected-crohns-disease","fullItemName":"Scenario: Suspected Crohn's disease"},{"id":"b3e71531-764c-58b2-aa02-ece1993fb53f","slug":"confirmed-crohns-disease","fullItemName":"Scenario: Confirmed Crohn's disease"},{"id":"b822e9cd-227b-54db-9bfd-57cf52a4e663","slug":"fertility-pregnancy-breastfeeding-with-crohns-disease","fullItemName":"Scenario: Fertility, pregnancy, and breastfeeding with Crohn's disease"},{"id":"9a2be3f2-65c0-5e62-9b89-9aef0f5df386","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"82ab51ab-f7f0-5464-a0dc-cb566bb3f629","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"771b1e3f-3c10-5c86-bbb4-5ff669ca2d44","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"fb296c54-fd91-56fc-ab19-6fd4bb759030","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"efff8f5f-5a26-5e56-a428-b3155279fcef","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"420029a0-c51b-5ffc-a7f3-71940eccb5ba","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"09872916-a68f-57e9-b064-aab1b782ca32","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"dc3e796d-dda1-58f4-b43f-f4ce100ebfc2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a0922fda-b50c-5cff-8ccd-19fef4fe47f1","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a49169c9-856e-51c3-94cc-76e3f02f6073","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"4e09df95-bfc2-5a53-9206-e6d9f0bbed0b","slug":"review-in-primary-care","fullItemName":"Review in primary care","depth":3,"htmlHeader":"<!-- begin field ee2be096-1182-415b-b35e-bc11dfb7cbde --><h3>How should I review a person with confirmed Crohn's disease in primary care?</h3><!-- end field ee2be096-1182-415b-b35e-bc11dfb7cbde -->","summary":null,"htmlStringContent":"<!-- begin item fa4ce9c5-89e3-4537-a026-c1b2ca1dd899 --><!-- begin field 3412ab81-32b5-4aff-bd5b-895d6ddf143b --><ul><li><strong>Assess the impact of symptoms on daily functioning,</strong> such as home, work, school, and leisure activities, and assess for associated anxiety and/or depression. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a>, <a class=\"topic-reference external-reference\" href=\"/topics/depression-in-children/\">Depression in children</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a> for more information.</li><li><strong>Provide advice on Crohn's disease and offer sources of information and support:</strong><ul><li>Explain that Crohn's disease is a lifelong condition, which may have unpredictable relapses and remissions. Specialist drug treatments aim to induce remission of the disease and to treat symptoms, and occasionally surgical treatments may be necessary.</li><li>Crohn's and Colitis UK is a national charity that provides support for people with Crohn's disease and their families (website available at <a href=\"https://www.crohnsandcolitis.org.uk/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"d6a00ba4-f4a1-4b92-9f4d-a98e0144fa24\">www.crohnsandcolitis.org.uk</a>; telephone information service 0300 2225700 and an emotional support helpline 0121 7379931). It publishes a range of <a href=\"https://www.crohnsandcolitis.org.uk/about-inflammatory-bowel-disease/quick-list\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"8f74adb0-99ea-470e-a00d-a98e0144fb06\">information sheets and booklets</a> including <a href=\"http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/crohns-disease.pdf\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"7ac4ae45-75fb-4a71-ad3a-a98e0144fba5\">Crohn's disease. Your guide</a> and <a href=\"http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/IBD-in-children.pdf\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"29a80f8c-8b2f-44fb-a748-a98e0144fbb9\">IBD in children: a parent's guide</a>, and provides information on managing symptoms, drug treatments, diet, pregnancy, education, employment, and travel.</li><li>CICRA (Crohn's in Childhood Research Association) is a national charity that supports children and young people with inflammatory bowel disease (website available at <a href=\"http://www.cicra.org/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"e66daf88-01a8-4f0d-bd57-a98e0144fbca\">www.cicra.org</a>), which provides patient information and young people's forums for peer support.</li></ul></li><li><strong>Encourage the person to stop smoking,</strong> if needed and appropriate, as this may reduce the risk of relapse. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/smoking-cessation/\">Smoking cessation</a> for more information.<ul><li>The Crohn's and Colitis UK patient information sheet <a href=\"http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/smoking-and-IBD.pdf\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"a28bf58e-9018-4470-aa5f-a98e0144fc47\">Smoking and IBD</a> has some useful information.</li></ul></li><li><strong>Assess the person's risk of osteoporosis,</strong> including dietary calcium intake, and extent of Crohn's disease and history of small bowel resection, and manage appropriately. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/osteoporosis-prevention-of-fragility-fractures/\">Osteoporosis - prevention of fragility fractures</a> for more information.<ul><li>The Crohn's and Colitis UK patient information sheet <a href=\"http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/bones-and-IBD.pdf\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"570595f2-06b4-40e4-98a7-a98e0144fc58\">Bones and IBD</a> has some useful information.</li></ul></li><li><strong>Ensure that the person has follow-up arranged with a gastroenterology specialist, if needed, and encourage the person to attend appointments regularly.</strong><ul><li>Ensure the person is aware of the need for colorectal cancer surveillance and has colonoscopy screening arranged by the specialist team if symptoms started 10 years ago and there is Crohn's colitis affecting more than one segment of colon. The frequency of subsequent monitoring is a specialist decision, depending on the severity and duration of colitis, presence of co-morbid conditions, and the appearances at colonoscopy.</li><li>The Crohn's and Colitis UK patient information sheet <a href=\"http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/bowel-cancer-and-IBD.pdf\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"57d1ab1f-6104-4073-99dd-a98e0144fc68\">Bowel cancer and IBD</a> has some useful information.</li></ul></li><li><strong>If a shared-care agreement is in place, p</strong><strong><strong>rescrib</strong>e and monitor <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/management/confirmed-crohns-disease/#specialist-treatments\">specialist drug treatments</a></strong>, if appropriate, and encourage the person to take their medication regularly as prescribed.<ul><li>Monitoring may include checking serum ferritin, vitamin B<sub>12</sub>, folate, calcium, and vitamin D levels, and arranging supplementation where appropriate. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-iron-deficiency/\">Anaemia - iron deficiency</a>, <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a>, <a class=\"topic-reference external-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/\">Vitamin D deficiency in adults - treatment and prevention</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/vitamin-d-deficiency-in-children/\">Vitamin D deficiency in children</a> for more information.</li><li>Note that specialist drug treatments for the induction and maintenance of remission in Crohn's disease should always be initiated by a specialist. If there are any uncertainties regarding adverse effects or safety of drug treatments, seek specialist advice.</li></ul></li><li><strong>Assess for clinical features suggesting a Crohn's <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/management/confirmed-crohns-disease/#management-of-a-crohns-flare-up\">disease flare-up</a> or other troublesome <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/management/confirmed-crohns-disease/#management-of-symptoms\">symptoms</a>, </strong>and manage appropriately. Consider checking:<ul><li>The person's body mass index (BMI), and for unintended weight loss or signs of malnutrition.</li><li>The serum C-reactive protein (CRP) level if a flare-up is suspected, as an increased level may indicate a severe relapse requiring hospital admission. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/management/confirmed-crohns-disease/#management-of-a-crohns-flare-up\">How should I manage a person with a Crohn's disease flare-up?</a> for more information.</li></ul></li><li><strong>Arrange a referral to an appropriate specialist</strong> (such as rheumatology, dermatology, or ophthalmology) if appropriate, if there are suspected <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/background-information/extra-intestinal-manifestations/\">extra-intestinal manifestations</a>.</li><li><strong>If the person is taking <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/management/confirmed-crohns-disease/#specialist-treatments\">immunosuppressive</a> or <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/management/confirmed-crohns-disease/#specialist-treatments\">biologic therapy</a>, ensure they are aware that:</strong><ul><li>Live vaccines are contraindicated, and these vaccines should only be given before the start of specialist treatment, or else postponed for at least 6 months after stopping this therapy.</li><li>They are at increased risk of influenza and pneumococcal infection and should receive appropriate vaccinations regularly. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-seasonal-influenza/\">Immunizations - seasonal influenza</a> and <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-pneumococcal/\">Immunizations - pneumococcal</a> for more information.</li></ul></li></ul><!-- end field 3412ab81-32b5-4aff-bd5b-895d6ddf143b --><!-- end item fa4ce9c5-89e3-4537-a026-c1b2ca1dd899 -->","subChapters":[{"id":"da4430c9-bb97-5c57-84d4-a5de7eeb7017","slug":"specialist-treatments","fullItemName":"Specialist treatments","depth":4,"htmlHeader":"<!-- begin field bd5ae4eb-9158-4c82-9743-a7c1010df380 --><h4>Specialist treatments</h4><!-- end field bd5ae4eb-9158-4c82-9743-a7c1010df380 -->","summary":null,"htmlStringContent":"<!-- begin item 9898c42d-c537-4f60-ad69-a7c1010df1b4 --><!-- begin field b7ecc803-4780-451a-a19d-a7c1010df380 --><ul><li><strong>Specialist drug treatments for Crohn's disease are generally given for induction of remission and maintenance of remission. </strong><ul><li><strong>Options include:</strong><ul><li><strong>Corticosteroids</strong> — monotherapy with corticosteroids (such as prednisolone) may be used for induction of remission, with the aim to gradually taper the dose according to disease severity and the person's response to treatment. Corticosteroids should not be used to maintain clinical remission.</li><li><strong>Immunosuppressive drugs</strong> — the thiopurines (azathioprine, mercaptopurine) or methotrexate (second-line) may be added to corticosteroid therapy to induce remission if there are two or more inflammatory exacerbations in a 12-month period, or if the corticosteroid dose cannot be tapered as planned. These drugs are are also effective at maintaining remission. Thiopurines may increase the person's risk of non-melanoma skin cancer, and people should be monitored for skin cancer and given appropriate sun protection advice.</li><li><strong>Biologic therapy </strong>— the anti-tumour necrosis factor alpha monoclonal antibody agents infliximab and adalimumab are effective at inducing remission in people with severe active disease which has not responded to conventional therapy, or where conventional therapy is not tolerated; for treating perianal disease; and for maintaining remission.</li><li><strong>Aminosalicylates</strong> — mesalazine and sulfasalazine may be considered for a first presentation, or a single inflammatory exacerbation in a 12-month period, if corticosteroids are contraindicated or not tolerated.</li></ul></li><li>See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-oral/\">Corticosteroids - oral</a> and <a class=\"topic-reference external-reference\" href=\"/topics/dmards/\">DMARDs</a> for detailed prescribing information on these groups of drugs.</li></ul></li><li><strong>Specialist enteral nutritional supplementation may be used as an alternative</strong> to conventional corticosteroid drug treatment for induction of remission in children and young people who have faltering growth or development, or if there are concerns about adverse effects of corticosteroids.<ul><li>Note that evidence does not support the use of enteral nutrition for the maintenance of remission in adults.</li></ul></li><li><strong>To maintain remission</strong> <strong>in people with ileocolonic Crohn's disease who have had a complete macroscopic resection within the last 3 months,</strong> the National Institute for Health and Care Excellence (NICE) recommends that azathioprine in combination with up to 3 months' postoperative metronidazole should be considered. Monotherapy with <a class=\"topic-reference external-reference\" href=\"/topics/dmards/management/azathioprine/\">azathioprine</a> should be considered for people who cannot tolerate metronidazole [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">NICE, 2019</a>]. Biologics should not be used to maintain clinical remission after complete macroscopic resection of ileocolonic Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">NICE, 2019</a>]. </li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">British Society of Paediatric Gastroenterology, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Baumgart, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Ruemmele, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Forbes, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">National Clinical Guideline Centre, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">NICE, 2019</a>]</p><!-- end field b7ecc803-4780-451a-a19d-a7c1010df380 --><!-- end item 9898c42d-c537-4f60-ad69-a7c1010df1b4 -->","subChapters":[]},{"id":"687c59d2-1637-58fb-807b-e61750aba3fa","slug":"basis-for-recommendation-17c","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 6ae5d578-7dc9-4099-b588-b6f9b24e7bad --><h4>Basis for recommendation</h4><!-- end field 6ae5d578-7dc9-4099-b588-b6f9b24e7bad -->","summary":null,"htmlStringContent":"<!-- begin item 17c4ebcc-a79f-4d64-a99e-05e73c5b34f2 --><!-- begin field 80649037-8dce-425e-87c9-d21a7a9c831b --><p>The recommendations on review in primary care are based on expert opinion in the National Institute for Health and Care Excellence (NICE) clinical guidelines <em>Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn's disease or adenomas</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">NICE, 2011</a>], <em>Crohn's disease. Management in adults, children and young people</em> (full NICE guideline) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">National Clinical Guideline Centre, 2019</a>], and<em> </em><em>Crohn's disease: management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">NICE, 2019</a>]; the European Crohn's and Colitis Organisation (ECCO) publications <em>3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016. Part 1: Diagnosis and medical management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>], <em>European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Dignass, 2015</a>], and <em>The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Harbord, 2016</a>]; the European Society for Clinical Nutrition and Metabolism (ESPEN) guideline <em>Clinical nutrition in inflammatory bowel disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Forbes, 2017</a>], the British Society of Gastroenterology (BSG) <em>Guidelines for the management of inflammatory bowel disease in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>], the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition (BSPGHAN) consensus document <em>Guidelines for the management of inflammatory bowel disease in children in the United Kingdom</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">British Society of Paediatric Gastroenterology, 2010</a>], and expert opinion in review articles on Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Baumgart, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>] and inflammatory bowel disease in children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Oliveira, 2017</a>].</p><h5>Assessing the impact of symptoms</h5><ul><li>This recommendation is based on the fact that inflammatory bowel disease can affect psychosocial functioning [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Oliveira, 2017</a>], and the incidence of anxiety and depression is higher in people with inflammatory bowel disease than in control populations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>].</li></ul><h5>Offering sources of information and support</h5><ul><li>This recommendation is based on the NICE clinical guideline on Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">NICE, 2019</a>] and the BSG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>].</li></ul><h5>Advice on smoking cessation</h5><ul><li>The recommendation on smoking cessation is based on the NICE clinical guideline on Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">NICE, 2019</a>], the ECCO consensus paper on diagnosis and management of Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>].<ul><li>The ECCO consensus paper cites observational studies that show smoking increases the need for corticosteroid and immunosuppressive drug treatment, as well as surgical treatment of Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>].</li><li>In addition, expert opinion in a review article states that smoking cessation can be as effective as immunosuppressive therapy and can reduce the risk of relapse by 65% compared with continued smoking [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>].</li></ul></li></ul><h5>Assessing osteoporosis risk</h5><ul><li>This recommendation is based on expert opinion which states that people with Crohn's disease are at increased risk of osteoporosis, due to factors such as potential intermittent corticosteroid use and reduced micronutrient intake and absorption, for example, if there is small bowel disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>].</li><li>The ECCO consensus paper on extra-intestinal manifestations of inflammatory bowel disease cites a large study which found tight control of disease activity and supplementation of calcium and vitamin D were associated with a median annual increase in bone mineral density of 0.76% over 4 years [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Harbord, 2016</a>].</li><li>The BSPGHAN guideline recommends ensuring an adequate intake of calcium and vitamin D, and considering supplementation if this is insufficient [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">British Society of Paediatric Gastroenterology, 2010</a>].</li></ul><h5>Ensuring specialist follow-up and surveillance</h5><ul><li>The recommendations on colonoscopic surveillance for preventing colorectal cancer are based on the NICE guideline on colonoscopic surveillance for people with Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">NICE, 2011</a>].</li></ul><h5>Prescribing and monitoring drug treatments</h5><ul><li>This recommendation is based on the ECCO consensus paper on iron deficiency and anaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Dignass, 2015</a>], the ESPEN guideline on nutrition [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Forbes, 2017</a>], and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Oliveira, 2017</a>].<ul><li>Recurrent anaemia may indicate persistent disease activity even if there is clinical remission and serum inflammatory markers are normal [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Dignass, 2015</a>].</li><li>People with inflammatory bowel disease are at increased risk of malnutrition, and should be checked for nutritional deficiencies regularly [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Forbes, 2017</a>].</li></ul></li></ul><h5>Assessing for clinical features of a relapse</h5><ul><li>The recommendation on checking the person's body mass index (BMI) is extrapolated from the ESPEN guideline on nutrition, which states that as people with inflammatory bowel disease are at increased risk of malnutrition, they should be screened for this on a regular basis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Forbes, 2017</a>].<ul><li>People with malnutrition are more likely to be hospitalized, are at increased risk of infection and venous thromboembolism, and have increased mortality rates compared with people who are not malnourished.</li><li>In addition, malnourished children are at increased risk of growth failure and delayed pubertal development.</li></ul></li></ul><h5>Arranging referral for suspected extra-intestinal manifestations</h5><ul><li>This recommendation is extrapolated from the BSG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>], and is pragmatic, based on what CKS considers to be good clinical practice.</li></ul><h5>Advice on live vaccines</h5><ul><li>These recommendations are based on the BSG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Baumgart, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>].<ul><li>People with Crohn's disease may be at increased risk of opportunistic infections due to underlying disease activity, malnutrition, long-term immunosuppressive drug treatment, or surgery [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>].</li></ul></li></ul><!-- end field 80649037-8dce-425e-87c9-d21a7a9c831b --><!-- end item 17c4ebcc-a79f-4d64-a99e-05e73c5b34f2 -->","subChapters":[]}]},{"id":"2005e4a0-5097-5fdf-b25a-1cbc68606702","slug":"management-of-a-crohns-flare-up","fullItemName":"Management of a Crohn's flare-up","depth":3,"htmlHeader":"<!-- begin field 26a8d6eb-2dbe-44a4-9b4f-46c2625537a1 --><h3>How should I manage a person with a Crohn's disease flare-up?</h3><!-- end field 26a8d6eb-2dbe-44a4-9b4f-46c2625537a1 -->","summary":null,"htmlStringContent":"<!-- begin item 0bb78049-dd18-416f-84d7-cdfe362aa015 --><!-- begin field fb2bfaa9-8c3b-40d5-8d98-714892b28e60 --><ul><li><strong>Arrange an emergency hospital admission if the person has a suspected flare-up of Crohn's disease and is systemically unwell with severe symptoms, such as:</strong><ul><li>Severe diarrhoea (more than 6–8 stools a day).</li><li>Fever, dehydration, tachycardia, or hypotension.</li><li>Suspected intestinal obstruction or intra-abdominal or perianal abscess.</li><li>Cachexia with body mass index (BMI) less than 18.5 kg/m<sup>2</sup>, or unintended sudden weight loss.</li><li>Persistent symptoms despite optimal management in primary care.<ul><li>Note that a raised serum C-reactive protein (CRP) level may be suggestive of a severe disease flare-up.</li></ul></li></ul></li><li><strong>If admission to hospital is not indicated:</strong><ul><li>Consider whether symptoms may be due to an <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/diagnosis/differential-diagnosis/\">alternative diagnosis</a>, and manage appropriately.</li><li>Check the person's adherence to their current drug treatment regimen, and encourage them to take medication regularly and appropriately.</li><li>Consider arranging an urgent specialist gastroenterology review appointment or seeking specialist advice.<ul><li>Consider prescribing drug treatment for disease flare-ups according to the person's shared-care agreement, such as starting a tapered course of oral <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/management/confirmed-crohns-disease/#specialist-treatments\">corticosteroids</a>, if appropriate, whilst awaiting specialist review. Note: corticosteroids should not be started in people taking dual immunosuppressive or biologic therapy, and corticosteroids should not be used to maintain disease remission.</li></ul></li><li>Consider arranging a referral to a dietitian if there are signs of unintended weight loss or malnutrition.</li></ul></li><li><strong>If there are recurrent flares of disease activity, seek specialist advice regarding whether the person's maintenance treatment regimen needs to be changed, or whether <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/management/confirmed-crohns-disease/#management-of-symptoms\">surgery</a> may be needed.</strong></li></ul><!-- end field fb2bfaa9-8c3b-40d5-8d98-714892b28e60 --><!-- end item 0bb78049-dd18-416f-84d7-cdfe362aa015 -->","subChapters":[{"id":"f033988d-5a18-525f-a842-196337038029","slug":"basis-for-recommendation-4e3","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 97259b2f-a2fc-4321-a1ef-8183f543b0d4 --><h4>Basis for recommendation</h4><!-- end field 97259b2f-a2fc-4321-a1ef-8183f543b0d4 -->","summary":null,"htmlStringContent":"<!-- begin item 4e325629-2723-4476-99eb-5121ed46709d --><!-- begin field bb9a0092-df0d-4f42-b08e-238d8806a1ae --><p>The recommendations on management of a suspected relapse of Crohn's disease are based on the European Crohn's and Colitis Organisation (ECCO) publications <em>3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016. Part 1: Diagnosis and medical management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>] and <em>Practical guideline for fatigue management in inflammatory bowel disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kreijne, 2016</a>]; the European Society for Clinical Nutrition and Metabolism (ESPEN) guideline <em>Clinical nutrition in inflammatory bowel disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Forbes, 2017</a>], the British Society of Gastroenterology (BSG) <em>Guidelines for the management of inflammatory bowel disease in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>], and expert opinion in review articles on Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Baumgart, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>].</p><h5>Arranging urgent hospital admission</h5><ul><li>The body mass index (BMI) parameter is based on the ESPEN guideline on nutrition which states that this value reflects undernutrition and disease-associated catabolism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Forbes, 2017</a>].</li><li>The ECCO consensus paper on the diagnosis and management of Crohn's disease states that objective evidence of disease activity should be obtained (for example, using inflammatory markers) before diagnosing a flare-up of active Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>].</li></ul><h5>Management if admission not indicated</h5><ul><li>The recommendation on arranging an urgent gastroenterology review appointment or seeking specialist advice is based on the BSG clinical guideline, which states that people experiencing a possible relapse of their inflammatory bowel disease should have access to specialist review within five working days [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>]. This is supported by expert opinion in a review article which states that an expedited review appointment should be arranged in the event of a relapse of Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>].</li><li>The information on considering starting oral corticosteroids in primary care is based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>].</li><li>The recommendation on considering referral to a dietitian is extrapolated from the ESPEN guideline, which states that nutritional care is important, particularly in children, to promote optimal growth and pubertal development [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Forbes, 2017</a>].</li><li>The ECCO consensus paper on the diagnosis and management of Crohn's disease states that surgery may be considered for people with severely active localized ileocaecal Crohn's disease which is refractory to conventional medical treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>].</li></ul><!-- end field bb9a0092-df0d-4f42-b08e-238d8806a1ae --><!-- end item 4e325629-2723-4476-99eb-5121ed46709d -->","subChapters":[]}]},{"id":"3ed74acf-92ed-5d05-8303-0c946d4933e0","slug":"management-of-symptoms","fullItemName":"Management of symptoms","depth":3,"htmlHeader":"<!-- begin field 428a6cd4-2285-4aa0-a614-512e188eaab2 --><h3>How should I manage symptoms in people with Crohn's disease?</h3><!-- end field 428a6cd4-2285-4aa0-a614-512e188eaab2 -->","summary":null,"htmlStringContent":"<!-- begin item bee5eee1-bd72-4067-9a45-9b9c8bee29b8 --><!-- begin field 83b47a1f-dbc0-45a3-b380-a6d624892c92 --><p><strong>If there are troublesome symptoms associated with Crohn's disease, ensure that the person's maintenance treatment is optimal and seek specialist advice if necessary. The following management strategies may be appropriate in primary care or according to the person's shared-care agreement (if available).</strong></p><h4>Diarrhoea</h4><ul><li>Exclude any <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/diagnosis/differential-diagnosis/\">alternative cause</a> for diarrhoea symptoms, such as infection, abscess formation, dysmotility, bacterial overgrowth, bile salt malabsorption, or drugs, and manage appropriately.<ul><li>Suspect a diagnosis of bile salt malabsorption if there is watery diarrhoea accompanied by abdominal bloating and steatorrhoea (suggested by pale, floating stool), particularly if the person has extensive ileal disease or a history of distal ileal resection.</li><li>Diarrhoea may be secondary to drug treatment, such as laxatives, iron supplements, azathioprine, mercaptopurine, or methotrexate. Seek specialist advice regarding reducing or stopping medication, if necessary.</li></ul></li><li>If diarrhoea symptoms persist, consider whether symptomatic treatment is appropriate, following specialist advice if necessary. Options include:<ul><li>Anti-motility drugs which slow colonic transit (for example loperamide). See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/irritable-bowel-syndrome/\">Irritable bowel syndrome</a> for more information.</li><li>Anti-spasmodic drugs for pain relief (for example mebeverine). See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/irritable-bowel-syndrome/\">Irritable bowel syndrome</a> for more information.</li><li>Bulk-forming laxatives (for example ispaghula husk). See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/constipation/\">Constipation</a> and <a class=\"topic-reference external-reference\" href=\"/topics/constipation-in-children/\">Constipation in children</a> for more information.</li><li>A bile acid sequestrant (such as colestyramine) to bind bile salts, if a specialist diagnosis of bile acid malabsorption has been made and drug treatment has been previously prescribed by a specialist. If this is a new presentation or a bile acid sequestrant has not previously been prescribed, seek specialist advice.</li><li>Note: do not prescribe symptomatic treatment for people who are systemically unwell, have abdominal tenderness or <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/diagnosis/when-to-suspect/\">signs of intestinal obstruction</a>.</li></ul></li><li>Offer sources of information to help manage symptoms, such as the Crohn's and Colitis UK patient information sheets <a data-hyperlink-id=\"c7e6ecea-33a0-444c-9b25-a98f013a8086\" href=\"http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/diarrhoea-and-constipation.pdf\" target=\"_blank\">Diarrhoea and constipation</a>, <a data-hyperlink-id=\"b471f138-ccf5-45dc-ad27-a98f013a809b\" href=\"http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/managing-bowel-incontinence-in-IBD.pdf\" target=\"_blank\">Managing bowel incontinence in IBD</a>, and <a data-hyperlink-id=\"32642a5a-6fa4-43d1-800e-a98f013a80ac\" href=\"http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/bloating-and-wind.pdf\" target=\"_blank\">Managing bloating and wind</a>.</li></ul><h4>Fistulas and strictures</h4><ul><li>If a fistula or intestinal stricture is <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/diagnosis/when-to-suspect/\">suspected</a>:<ul><li>Arrange hospital admission, arrange a referral to colorectal surgery, or seek specialist advice, depending on clinical judgement. Specialist treatment depends on the location, scale, and nature of symptoms.<ul><li>Asymptomatic simple perianal fistulas may not need any specific treatment.</li><li>Specialist drug treatment of a fistula may be with long-term antibiotics (such as metronidazole or ciprofloxacin) to control infection.</li><li>Fistulas and strictures may be treated with <a class=\"topic-reference internal-reference\" href=\"/topics/crohns-disease/management/confirmed-crohns-disease/#specialist-treatments\">immunosuppressive drugs</a> to control inflammation.</li><li>Surgery may be indicated for intra-abdominal abscesses, complicated perianal or internal fistulas that fail to respond to optimal medical treatment, strictures with symptoms of partial or complete bowel obstruction, or in cases of severe infection.</li><li>An endoscopic procedure or surgery may be needed to dilate or excise an intestinal stricture.</li></ul></li><li>Offer sources of information, such as the Crohn's and Colitis UK patient information sheets <a data-hyperlink-id=\"8fe6f096-ec8c-4783-9658-a98f013a80be\" href=\"http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/fistula\" target=\"_blank\">Living with a fistula</a> and <a data-hyperlink-id=\"dda38c93-e881-4613-9b95-a98f013a80cf\" href=\"http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/surgery-for-crohns-disease.pdf\" target=\"_blank\">Surgery for Crohn's disease</a>.</li></ul></li></ul><h4>Upper gastrointestinal symptoms</h4><ul><li>If the person has previously been investigated for upper gastrointestinal symptoms, manage the underlying cause appropriately. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/dyspepsia-proven-gord/\">Dyspepsia - proven GORD </a>, <a class=\"topic-reference external-reference\" href=\"/topics/dyspepsia-proven-peptic-ulcer/\">Dyspepsia - proven peptic ulcer</a>, <a class=\"topic-reference external-reference\" href=\"/topics/dyspepsia-proven-functional/\">Dyspepsia - proven functional</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/dyspepsia-pregnancy-associated/\">Dyspepsia - pregnancy-associated</a> for more information.</li><li>Assess for any alarm symptoms that may suggest serious underlying pathology, and manage appropriately. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gastrointestinal-tract-upper-cancers-recognition-referral/\">Gastrointestinal tract (upper) cancers - recognition and referral</a> for more information.</li><li>For other people, consider whether Crohn's disease may be affecting the stomach or duodenum, and manage appropriately. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dyspepsia-unidentified-cause/\">Dyspepsia - unidentified cause</a> for more information.<ul><li>Consider checking serum full blood count and C-reactive protein (CRP) to assess for anaemia and disease activity.</li></ul></li></ul><h4>Abdominal or perianal pain</h4><ul><li>Identify the underlying cause for abdominal or perianal pain, wherever possible, to allow appropriate management.<ul><li>Persistent severe pain may indicate poor disease control or complications, such as pending perforation.</li><li>If a person has Crohn's disease with suspected perianal sepsis or fistula, arrange urgent hospital admission for examination under anaesthesia to consider whether surgical drainage is needed.</li></ul></li><li>Offer analgesia to help relieve symptoms.<ul><li>Consider paracetamol first-line. Opiates may be needed for additional symptom relief. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> for more information.</li><li>Advise the person to avoid nonsteroidal anti-inflammatory drugs (NSAIDs) wherever possible, as they may aggravate Crohn's disease.</li></ul></li><li>If pain is not effectively controlled with optimal analgesia in primary care, consider arranging referral to a chronic pain service, for specialist management.</li></ul><h4>Fatigue</h4><ul><li>Exclude any alternative or contributing cause for persistent fatigue (such as pain, anaemia, reduced nutritional intake and activity levels, sleep disturbance, stress, anxiety, or depression), and manage appropriately. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/tiredness-fatigue-in-adults/\">Tiredness/fatigue in adults</a>, <a class=\"topic-reference external-reference\" href=\"/topics/insomnia/\">Insomnia</a>, <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a>, <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/depression-in-children/\">Depression in children</a> for more information.<ul><li>Consider checking serum full blood count, ferritin, vitamin B<sub>12</sub> and folate levels, as people with Crohn's disease can develop iron deficiency anaemia due to blood loss or decreased absorption; anaemia of chronic disease; anaemia secondary to nutritional deficiencies; or drug-induced anaemia secondary to mercaptopurine, azathioprine, or sulfasalazine, for example. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-iron-deficiency/\">Anaemia - iron deficiency</a> and <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a> for more information.</li><li>Be aware that the optimal management of anaemia of chronic disease involves induction of remission of Crohn's disease.</li></ul></li><li>Offer sources of information, such as the Crohn's and Colitis UK patient information sheet <a data-hyperlink-id=\"73269e37-5d93-4720-a9e8-a98f013a80e1\" href=\"http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/fatigue-and-IBD.pdf\" target=\"_blank\">Fatigue and IBD</a>.</li></ul><h4>Oral problems</h4><ul><li>If the person develops suspected oral lesions secondary to Crohn's disease (such as mucosal tags, 'cobblestoning' [close-packed mucosal nodules], aphthous ulcers, or angular cheilitis), arrange a gastroenterology clinic review appointment and/or referral to a specialist in oral medicine, depending on clinical judgement.<ul><li>Specialist treatments may include topical or intra-lesional corticosteroids, topical or systemic immunosuppressives or biologic agents, and enteral nutritional support.</li><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/aphthous-ulcer/\">Aphthous ulcer</a> for more information.</li></ul></li></ul><!-- end field 83b47a1f-dbc0-45a3-b380-a6d624892c92 --><!-- end item bee5eee1-bd72-4067-9a45-9b9c8bee29b8 -->","subChapters":[{"id":"5a9829f5-6740-591f-a9be-678df2006ef8","slug":"basis-for-recommendation-301","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 6b79fab0-ae93-4bef-b31d-8e9116a3f002 --><h4>Basis for recommendation</h4><!-- end field 6b79fab0-ae93-4bef-b31d-8e9116a3f002 -->","summary":null,"htmlStringContent":"<!-- begin item 30124421-3555-4831-968b-402a7a68af10 --><!-- begin field a9997ea4-a3a6-4bf2-8af6-b3bc9ca294b3 --><p>The recommendations on management of troublesome symptoms are based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Crohn's disease: management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">NICE, 2019</a>], the European Crohn's and Colitis Organisation (ECCO) publications <em>3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016. Part 1: Diagnosis and medical management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>], <em>Part 2: Surgical management and special situations</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gionchetti, 2017</a>], <em>European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Dignass, 2015</a>], and <em>Practical guideline for fatigue management in inflammatory bowel disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kreijne, 2016</a>]; the British Society of Gastroenterology (BSG) <em>Guidelines for the management of inflammatory bowel disease in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>], the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition (BSPGHAN) consensus document <em>Guidelines for the management of inflammatory bowel disease in children in the United Kingdom</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">British Society of Paediatric Gastroenterology, 2010</a>], the European Society for Clinical Nutrition and Metabolism (ESPEN) guideline <em>Clinical nutrition in inflammatory bowel disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Forbes, 2017</a>], and expert opinion in a review article on Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>] and on inflammatory bowel disease in children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Oliveira, 2017</a>].</p><h5>Management of diarrhoea</h5><ul><li>These recommendations are based on the ECCO consensus paper on the diagnosis and management of Crohn's disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>], the BSG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>], the ESPEN guideline on nutrition [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Forbes, 2017</a>], and are pragmatic, based on what CKS considers to be good clinical practice.</li></ul><h5>Management of fistulas and strictures</h5><ul><li><p>These recommendations are based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">NICE, 2019</a>], the BSG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>], the BSPGHAN guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">British Society of Paediatric Gastroenterology, 2010</a>], and the ESPEN guideline on nutrition [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Forbes, 2017</a>].</p></li></ul><h5>Management of upper gastrointestinal symptoms</h5><ul><li><p>These recommendations are based on the BSG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>].</p></li></ul><h5>Management of abdominal and perianal pain</h5><ul><li>The information that severe pain may indicate poor disease control is based on the BSPGHAN guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">British Society of Paediatric Gastroenterology, 2010</a>].</li><li>The recommendations on the use of opiate analgesia are based on the expert opinion of previous external reviewers of this CKS topic.</li><li>The recommendation to avoid nonsteroidal anti-inflammatory drug (NSAID) use is extrapolated from the BSG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>] and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>], as NSAIDs may exacerbate Crohn's disease.</li><li>The recommendation on urgent referral for examination under anaesthesia (EUA) is based the ECCO consensus paper on surgical management, which states that this is gold standard initial management of perianal fistula disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gionchetti, 2017</a>] and the BSG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>].</li></ul><h5>Management of fatigue</h5><ul><li><p>These recommendations are based on the ECCO consensus papers on iron deficiency and anaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Dignass, 2015</a>] and fatigue management [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kreijne, 2016</a>], the BSG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>], and the expert opinion of previous external reviewers of this CKS topic.</p></li></ul><h5>Management of oral problems</h5><ul><li><p>These recommendations are based on the BSPGHAN guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">British Society of Paediatric Gastroenterology, 2010</a>] and the BSG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>].</p></li></ul><!-- end field a9997ea4-a3a6-4bf2-8af6-b3bc9ca294b3 --><!-- end item 30124421-3555-4831-968b-402a7a68af10 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}